Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Royal Bank of Canada (TSX:RY)

169.78 UNCHANGED
Streaming Delayed Price Updated: 4:15 PM EDT, May 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Royal Bank of Canada

< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
UnitedHealth Regains Retail Confidence Amid After-Hours Rebound: Analysts React To CEO Exit, FY25 Guidance Suspension
At least two research firms said the stock may have bottomed following the “latest in a string of setbacks.” 
Via Stocktwits
1 Mid-Cap Stock to Target This Week and 2 to Ignore
Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. However, they face intense competition from... 
Via StockStory
Digital Ad Firm Trade Desk Rebounds With Better-Than-Expected Earnings
Trade Desk stock rose after the digital advertising firm rebounded with a better-than-expected Q1 after lowering expectations in early 2025. 
Via Investor's Business Daily
Wall Street Remains Overwhelmingly Bullish About This 9.2%-Yielding Dividend Stock Despite Economic Uncertainty and Volatility
Via The Motley Fool
Topics Economy Government World Trade
Exposures Interest Rates Political Tariff
2 Popular AI Stock to Sell Before They Fall 64% and 67%, According to Certain Wall Street Analysts
Via The Motley Fool
Topics Artificial Intelligence Government
Exposures Artificial Intelligence Political
$1000 Invested In RBC Bearings 15 Years Ago Would Be Worth This Much Today
Via Benzinga
Palantir Stock Plummets As Analysts Flag Valuation Risks Despite Q1 Revenue Beat
Analysts warn that while Palantir's execution is impressive, concerns remain that its stock trades at a valuation difficult to justify without further acceleration. 
Via Stocktwits
Topics Artificial Intelligence Earnings Government
Exposures Artificial Intelligence Financial Political
Neurocrine Biosciences Surges On 'Surprising' Momentum For Its Newest Drug
The company reported a strong start for its newest drug, Crenessity, which treats a hormonal disorder involving the adrenal glands. 
Via Investor's Business Daily
Vertex Pharmaceuticals Topples 12% On A Series Of First-Quarter Setbacks
The company paused a study of a cystic fibrosis treatment, right on the heels of a scrapped type 1 diabetes program. 
Via Investor's Business Daily
Topics Government Intellectual Property
Exposures Intellectual Property Political
Analysts Still Like Chevron, Cite Strong FCF & Balance Sheet As Key Amid OPEC And Recession Fears
B of A Securities analyst maintains Buy rating on Chevron Corp. despite mixed Q1 earnings. Reiterates attractive investment due to strong cash flow and financial position. RBC Capital Markets also... 
Via Benzinga
Topics Economy
Exposures Economy
Diamondback Energy Q1 Preview: Investors Eyeing Production Forecast Amid Oil Price Drop, Retail’s Divided
Wall Street expects the oil and gas producer to post adjusted earnings of $4.20 per share on revenue of $3.75 billion. 
Via Stocktwits
Topics World Trade
Exposures Tariff
2 Profitable Stocks with Promising Prospects and 1 to Brush Off
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow. 
Via StockStory
Cybersecurity Stocks: Artificial Intelligence Dominates RSA Conference But Monetization Still In Question
The RSA conference this week didn't deliver much breaking news on cybersecurity stocks but Wall Street analysts came away upbeat on industry trends. 
Via Investor's Business Daily
Topics Artificial Intelligence
Exposures Artificial Intelligence
2 Cash-Producing Stocks with Competitive Advantages and 1 to Avoid
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak... 
Via StockStory
Price Over Earnings Overview: RBC Bearings
Via Benzinga
Palantir's Government, Commercial Business Trends Eyed In Q1 Earnings
Palantir reports Q1 earnings on Monday, the data analytics software maker's government and commercial businesses will again be in focus. 
Via Investor's Business Daily
Topics Artificial Intelligence Earnings
Exposures Artificial Intelligence Financial
Here's How Much $100 Invested In RBC Bearings 15 Years Ago Would Be Worth Today
Via Benzinga
Visa's Q2 Results Reflect Steady US Spending Despite Market Uncertainty: Analyst Highlights Strength In Payment Volumes
Visa gains after RBC's Perlin highlights strong Q2 results, steady U.S. spending, and a $30B buyback plan. 
Via Benzinga
BridgeBio's Pfizer-Rivaling Heart Drug Just Obliterated Sales Expectations
The company sells a rival to Pfizer' heart treatment, Vyndaqel. Sales smashed expectations in its first quarter on the market. 
Via Investor's Business Daily
1 Industrials Stock to Consider Right Now and 2 to Approach with Caution
Industrials businesses quietly power the physical things we depend on, from cars and homes to e-commerce infrastructure. But they are at the whim of volatile macroeconomic factors that influence... 
Via StockStory
Topics Stocks
Exposures US Equities
DoorDash's Deliveroo Offer Seen As 'Meaningfully Expanding' Global Reach
DoorDash stock analysts were mostly positive on the company's offer to acquire U.K.-focused food delivery firm Deliveroo. 
Via Investor's Business Daily
CG Oncology Rockets On Its Johnson & Johnson-Rivaling Cancer Drug
The companies are working on treatments for a form of bladder cancer. 
Via Investor's Business Daily
Did Google Earnings Results Put Search Worries To Rest? Here's What Analysts Are Saying
Google stock climbed on better-than-expected Q1 earnings and search ad revenue as management touted the new AI Overviews format. 
Via Investor's Business Daily
Topics Artificial Intelligence
Exposures Artificial Intelligence
Unpacking Q4 Earnings: RBC Bearings (NYSE:RBC) In The Context Of Other Engineered Components and Systems Stocks
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at RBC Bearings (NYSE:RBC) and the best and... 
Via StockStory
Google Earnings Due. Here's What Could Move Alphabet Stock.
Google stock has retreated 20% in 2025 heading into Alphabet's Q1 earnings report. Google's internet search business is still top of mind for investors amid the rise of generative artificial... 
Via Investor's Business Daily
Topics Artificial Intelligence Economy
Exposures Artificial Intelligence Economy
Danaher Makes A Bullish Move On 'Solid' Report, Promising Tariffs Plan
The company's commentary on tariffs was a "pleasant surprise," according to one analyst. 
Via Investor's Business Daily
Topics Economy Government World Trade
Exposures Political Supply Chain Tariff
Are Hospital Stocks At Risk Amid Medicaid Funding Fears? RBC Downplays Worries While Retail Eyes Q1 Results
The Wall Street Journal highlighted UHS, THC and HCA as key beneficiaries of Medicaid supplemental payment programs that cost the federal government hundreds of billions. 
Via Stocktwits
Topics Government
Exposures Political
Chipotle Mexican Grill Q1 Preview: Retail Gets Bullish As Traders Eye Tariff Commentary, Expansion Plans
The burrito chain has maintained that it will not increase the prices of its menu items and will offset higher input costs through automation and other initiatives. 
Via Stocktwits
Topics World Trade
Exposures Tariff
Why Sarepta Therapeutics And Other Genetics Stocks Just Got A Sizable Boost
The new FDA commissioner had a few key ideas for the agency in an interview with Megyn Kelly. 
Via Investor's Business Daily
Topics Government
Exposures Political Product Safety
American Express' Solid Revenue, Spending Trends Drive Analyst Optimism
RBC analyst maintains Outperform rating on American Express (AXP) with $310 price target. AXP reports strong Q1 2025 results, reaffirms revenue and EPS outlook. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback